Pioneer in the Commitment to Drug Production Quality and Safety Activities - Jiangxi Bio
Published:
2022-05-21
Drug Safety Quality First Everyone Participates Keep Promises
Record Drug Production Quality and Safety Commitment Activity The Pioneer - Jiangxi Bio
Possesses 50 Many Years of biopharmaceutical history, Jiangxi Bio always places Drug Quality and safety as the top priority in enterprise operation and development First , adhering to the purpose of "making high-quality drugs for people worldwide," constantly reminding all staff with "quality matters, health entrusted," striving to be "skilled in process, compliant with regulations, proficient in technology, ensuring quality, daring to innovate" as new era enterprise owners, fully creating high-quality, efficient, and excellent drugs .
Drug Quality can only be perfect, not just passing. Drugs, as a special type of commodity, their quality directly affects patients' physical and mental health and even concerns patients' life safety. As drug manufacturers, drug production quality and safety are the lifeline and value baseline of pharmaceutical companies.
Jiangxi Bio, as a pioneer in the biopharmaceutical industry, always insists that quality is the life of the enterprise and the foundation for its growth and development. For many years the company has maintained high standards and strict requirements, actively promoting production quality and safety, implementing all quality management tasks, steadily advancing and continuously improving the quality management system construction, without any slack for decades.

On May 18, in response to the Jiangxi Provincial Drug Administration's special rectification action on drug safety, to effectively implement the "Four Strictest" requirements of drug supervision, the company organized all employees in the third-floor conference room to carry out a drug production quality and safety commitment activity.
Quality leader Zhong Yuling presided over the event. She stated at the opening, "Cherish life, quality first" is easy to write but hard to do! Indeed, life is only once, and it is the most incomparable treasure in the world. Drug quality and safety directly relate to human life safety; it is like a long bond, where pulling one hair affects the whole body, concerning the survival of both the enterprise and patients. Therefore, focusing on drug production quality and safety is focusing on patients' lives and ourselves. Drug quality, as the top priority of the company's work, must not be empty talk. As members of the company, we must properly position the relationship between drug quality and work, enhance quality awareness, fulfill commitment content, solidify production quality, promptly eliminate unsafe factors, rigorously investigate and rectify production quality hazards, always be in a "walking on thin ice" state, consciously implement all laws and regulations, strictly standardize operations, proactively master necessary job knowledge, transform business theory into production quality skills, and build a solid product quality barrier.

At the meeting, General Manager Yao Xiaodong read the "Drug Production Quality and Safety Commitment Letter." Under the supervision of all employees, he made a commitment to comply with drug regulations and consciously ensure drug production quality and safety. He called on all employees to raise awareness of drug production quality and safety, fully implement the "Four Strictest" requirements, remain vigilant and not negligent during daily production because drug safety concerns patients' health and social stability. Ensuring drug production quality and safety relates to people's livelihood and the company's development plan. Therefore, first, establish a correct professional outlook and cultivate good quality awareness. Love and dedication to the job create a sense of responsibility, loyalty to the company and work, ensuring drug quality, and becoming pioneers who consciously abide by company rules and drug production quality management standards. Second, all employees should act immediately, actively implement all policy requirements, improve the drug production quality management system, further identify potential loopholes in drug production quality and safety, take timely measures for discovered problems, improve the pharmacovigilance system, and truly produce "conscientious drugs" that reassure the public, providing a guarantee for the company's high-quality and rapid development. Third, firmly establish the concept of ensuring continuous compliance with legal requirements throughout the drug production process, regard quality as life, organize production strictly according to drug GMP requirements and approved production processes, strengthen quality control at every stage of drug production, implement comprehensive quality management involving all employees, all aspects, and all processes to ensure drug safety.

(Content of the Commitment Letter)
At the meeting, General Manager Yao required all departments and personnel at all levels to act immediately, with standards higher than those in the commitment letter, to further strengthen and solidify all work related to drug production quality and safety, fulfill all commitments, and build a strong "moat" for product safety and quality construction. At the same time, the company welcomes employees and the public to supervise the fulfillment of our commitments!
Finally, General Manager Yao emphasized: Production quality only has a starting point, no end point. He hopes all employees improve their drug production quality and safety competence, achieve "everyone, everything, every time, everywhere" quality control, realize the transformation from "quality required of me" to "I want quality" and "I can ensure quality," thereby effectively promoting the company's continuous and stable improvement in production quality, ensuring effective drug production quality and safety, and driving the company's high-quality drug development.
Add:
Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China
Board Office:
Complaint & Report Hotline:
Pharmacovigilance Hotline:
Company Email:
Investor Relations:
International Sales Email:
Complaint/Report Email:
WeChat mini-site
WeChat official account
© Copyright 2025 Jiangxi Institute of Biological Products Inc. | SEO
Powered by www.300.cn